iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionPrivate Trust Co Na
Latest Disclosed Ownership965 shares
Latest Disclosed Value $ 162,940
Private Trust Co Na reports 26.56% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 30, 2026 - Private Trust Co Na filed a 13F-HR form disclosing ownership of 965 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $162,940 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 1,314 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -26.56% during the quarter. The current value of the position is $126,463 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 965 -349 -26.56 163 -26.70 0.0146
2026-01-26 2025-12-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 1,314 826 169.26 222 215.71 0.0194
2025-10-15 2025-09-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 488 86 21.39 70 40.00 0.0062
2025-07-29 2025-06-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 402 -51 -11.26 51 -12.28 0.0048
2025-04-28 2025-03-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 453 -160 -26.10 58 -29.63 0.0060
2025-02-05 2024-12-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 613 -2,883 -82.47 81 -84.09 0.0083
2024-11-13 2024-09-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 3,496 -17 -0.48 509 5.60 0.0513
2024-07-23 2024-06-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 3,513 2,439 227.09 482 227.89 0.0519
2024-04-24 2024-03-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 1,074 -19 -1.74 147 -0.68 0.0159
2024-01-24 2023-12-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 1,093 -4,000 -78.54 148 -76.21 0.0174
2023-10-18 2023-09-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 5,093 -194 -3.67 623 -7.30 0.0822
2023-07-28 2023-06-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 5,287 0 0.00 671 -1.61 0.0847
2023-04-12 2023-03-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 5,287 -278 -5.00 683 0.0931
2023-01-18 2022-12-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 5,565 80 1.46 1 -100.00 0.1085
2022-10-17 2022-09-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 5,485 1,094 24.91 642 24.18 0.1043
2022-09-16 2022-06-30 13F/A-1 IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 4,391 -2,594 -37.14 517 -43.19 0.0803
2022-07-13 2022-06-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,985 0 910 0.1421
2022-04-12 2022-03-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,985 728 11.63 910 -4.71 0.1421
2022-01-10 2021-12-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,257 -90 -1.42 955 -6.92 0.1318
2021-10-06 2021-09-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,347 700 12.40 1,026 11.04 0.1493
2021-07-07 2021-06-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 5,647 82 1.47 924 10.39 0.1400
2021-04-06 2021-03-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 5,565 -150 -2.62 837 -3.24 0.1359
2021-01-05 2020-12-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 5,715 -887 -13.44 865 -3.14 0.1457
2020-10-01 2020-09-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,602 23 0.35 893 -1.98 0.1723
2020-07-07 2020-06-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,579 -146 -2.17 911 25.83 0.1910
2020-04-07 2020-03-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,725 410 6.49 724 -4.86 0.1874
2020-01-02 2019-12-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,315 0 0.00 761 21.18 0.1412
2019-10-01 2019-09-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,315 283 4.69 628 -4.56 0.1238
2019-07-02 2019-06-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,032 -138 -2.24 658 -4.50 0.1327
2019-04-02 2019-03-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,170 0 0.00 689 15.99 0.1433
2019-01-03 2018-12-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 6,170 1,054 20.60 594 -4.65 0.1411
2018-10-09 2018-09-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 5,116 0 0.00 623 11.05 0.1271
2018-07-03 2018-06-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 5,116 188 3.81 561 6.65 0.1216
2018-04-03 2018-03-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 4,928 390 8.59 526 8.68 0.1150
2018-01-16 2017-12-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 4,538 3,120 220.03 484 2.33 0.1024
2017-10-12 2017-09-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 1,418 31 2.24 473 10.00 0.1029
2017-07-11 2017-06-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 1,387 224 19.26 430 26.10 0.0938
2017-04-13 2017-03-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 1,163 -532 -31.39 341 -24.05 0.0788
2017-01-17 2016-12-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 1,695 197 13.15 449 3.70 0.1075
2016-10-13 2016-09-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 1,498 -36 -2.35 433 10.18 0.1055
2016-07-19 2016-06-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 1,534 9 0.59 393 -1.01 0.1022
2016-04-18 2016-03-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 1,525 -1,231 -44.67 397 -57.36 0.1075
2016-01-19 2015-12-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 2,756 221 8.72 931 21.22 0.2652
2015-10-27 2015-09-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 2,535 336 15.28 768 -5.19 0.2301
2015-07-10 2015-06-30 13F IShares Tr Nasdaq Biotechnology Equities 464287556 2,199 103 4.91 810 12.66 0.2322
2015-04-09 2015-03-31 13F IShares Tr Nasdaq Biotechnology Equities 464287556 2,096 1,928 1,147.62 719 1,954.29 0.2059
2013-10-07 2013-09-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 168 0 0.00 35 20.69 0.0158
2013-08-01 2013-06-30 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 168 0 0.00 29 0.00 0.0133
2013-07-26 2013-03-31 13F IShares Tr Nasdaq Biotechnology Index Fd Com 464287556 168 168 29 0.0133
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.